Skip to main content
Full access
Letters
Published Online: 1 October 2013

A Novel Case Report: Acute Manic Psychotic Episode After Treatment With Niacin

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
To the Editor: Awareness of the role of food supplements for various medical problems has been increasing in recent years. Niacin (Vitamin B3) has been proven to raise HDL and lower triglyceride levels.1 Niacin is a precursor to several neurotransmitters in the brain, which may have an impact on mood. Niacin sensitivity is inversely correlated with severity of symptoms, and flush deficits were significantly associated with depressed mood and anxiety.2 Except for hot flushes, it is considered to be a safe medication.
We describe a case of an acute, manic-like psychotic episode that was temporally associated with treatment and dosage of niacin.
“Mr. F,” a 52-year-old man without psychiatric history or psychiatric disorders within his immediate family and no recent stressors in his life. His behavior changed a week before admission and followed an increase in the dosage of niacin, which he took for dyslipidemia. He began niacin, 500 mg QD, 2 months earlier. He complained of hot flushes. Because of the absent effect on his lipid profile, his family physician increased the dose of niacin to 1,000mg QD. Within a week after this dose increase, he displayed elevated mood; labile affect; psycho-motor agitation; a run of thoughts; tangentiality; delusions of grandeur, persecution, and reference; and delusions of thought-broadcasting.
Upon admission, he was severely agitated and negativistic. His CBC and basic chemistry were within normal limits. He did not display gross neurological deficits. He received a single dose of IM haloperidol 10 mg and diazepam 10 mg.
On the next day, his status examination was without any evidence of psychotic or affective signs or symptoms. Mr. F was discharged under treatment with risperidone 1 mg daily and was recommended to avoid taking niacin. He came to follow-up visits during the next week and was without any abnormal findings.
After discharge, he took risperidone for an additional week and stopped on his own. He returned to his past routines, including a full-time job. On a follow-up phone call 5 months later, the patient and his family reported a lack of psychiatric symptoms altogether.
A PubMed search for correlation of niacin and psychotic or affective side effects was negative. However, in a private website that analyzes FDA and user reports of drug adverse events, this search yielded four reports of mania related to niacin treatment.3
This case highlights the possibility of acute, manic-like psychotic episodes caused by high doses of niacin. The role of niacin in the synthesis of amino acids, such as tryptophan, with the resulting stimulation of production of serotonin and dopamine can suggest an explanation of this kind of reaction in a sensitive patient. This case also represents the issue of using alternative e-health resources beyond medical journals.

References

1.
Ito MK: The metabolic syndrome: pathophysiology, clinical relevance, and use of niacin. Ann Pharmacother 2004; 38:277–285
2.
Smesny S, Baur K, Rudolph N, et al.: Alterations of niacin skin sensitivity in recurrent unipolar depressive disorder. J Affect Disord 2010; 124:335–340

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: E14
PubMed: 24247871

History

Published online: 1 October 2013
Published in print: Fall 2013

Authors

Affiliations

Tsafrir Loebl, M.D.
Kfar Shaul Psychiatric HospitalThe Jerusalem Mental Health CenterAffiliated with Hadassah Medical School, The Hebrew UniversityJerusalem 91060, Israel
Sergey Raskin, M.D.
Kfar Shaul Psychiatric HospitalThe Jerusalem Mental Health CenterAffiliated with Hadassah Medical School, The Hebrew UniversityJerusalem 91060, Israel

Notes

Correspondence: Tsafrir Loebl, M.D.; e-mail: [email protected]

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share